As of 2026-05-26, the Relative Valuation of Sun Pharma Advanced Research Co Ltd (SPARC.NS) is 21,240.28 INR. This relative valuation is based on P/E multiples. With the latest stock price at 235.57 INR, the upside of Sun Pharma Advanced Research Co Ltd based on Relative Valuation is 8916.5%.
The range of the Relative Valuation is 1,141.97 - 50,236.84 INR.
| Range | Selected | |
| Trailing P/E multiples | 23.9x - 29.1x | 26.6x |
| Forward P/E multiples | 23.3x - 31.9x | 26.2x |
| Fair Price | 1,141.97 - 50,236.84 | 21,240.28 |
| Upside | 384.8% - 21225.7% | 8916.5% |
| Date | P/E |
| 2026-05-26 | 4.92 |
| 2026-05-25 | 4.93 |
| 2026-05-22 | 4.45 |
| 2026-05-21 | 3.76 |
| 2026-05-20 | 3.82 |
| 2026-05-19 | 3.76 |
| 2026-05-18 | 3.38 |
| 2026-05-15 | 3.43 |
| 2026-05-14 | 3.58 |
| 2026-05-13 | 3.52 |
| 2026-05-12 | 3.47 |
| 2026-05-11 | 3.53 |
| 2026-05-08 | 3.62 |
| 2026-05-07 | 3.49 |
| 2026-05-06 | 3.28 |
| 2026-05-05 | 2.93 |
| 2026-05-04 | 2.92 |
| 2026-04-30 | 2.98 |
| 2026-04-29 | 3.12 |
| 2026-04-28 | 3.07 |
| 2026-04-27 | 3.07 |
| 2026-04-24 | 2.89 |
| 2026-04-23 | 2.99 |
| 2026-04-22 | 3.00 |
| 2026-04-21 | 3.02 |
| 2026-04-20 | 3.02 |
| 2026-04-17 | 3.08 |
| 2026-04-16 | 3.18 |
| 2026-04-15 | 3.14 |
| 2026-04-13 | 2.97 |
| 2026-04-10 | 3.09 |
| 2026-04-09 | 3.04 |
| 2026-04-08 | 2.86 |
| 2026-04-07 | 2.63 |
| 2026-04-06 | 2.57 |
| 2026-04-02 | 2.58 |
| 2026-04-01 | 2.52 |
| 2026-03-30 | 2.41 |
| 2026-03-27 | 2.51 |
| 2026-03-25 | 2.73 |
| 2026-03-24 | 2.34 |
| 2026-03-23 | 2.27 |
| 2026-03-20 | 2.40 |
| 2026-03-19 | 2.41 |
| 2026-03-18 | 2.49 |
| 2026-03-17 | 2.40 |
| 2026-03-16 | 2.39 |
| 2026-03-13 | 2.44 |
| 2026-03-12 | 2.55 |
| 2026-03-11 | 2.60 |